Vanderbilt University Medical Center
Nashville, Tennessee, 37232, United States
NCT Number: NCT07736105
This research study is investigating the efficacy and implementation of expiratory muscle strength training (EMST), standard of care dysphagia treatment, and intensive dysphagia treatment in critically ill adults in the acute care setting. Currently, no targeted, effective, and feasible dysphagia treatment approaches currently exist for use in critically ill adults in the acute care setting. The current study will investigate the impact of EMST, standard of care dysphagia treatment, and intensive dysphagia treatment on pulmonary function, cough function, swallow function, frailty, patient-reported swallow function, and health outcomes in critically ill adults. This study will also examine patient perceptions and clinical speech-language pathologists' perceptions of the acceptability, appropriateness, and feasibility of these interventions.
Critically ill adults will: undergo tests of breathing, cough, and swallow function, complete questionnaires about the treatment, and their swallow function, and complete their respective treatment as prescribed.
Clinical speech-language pathologists will complete questionnaires about the interventions.
A subset of critically ill adults and clinical speech-language pathologists will also have the opportunity to participate in focus groups.
Trial opening soon.
Get Notified18 year and older
All sexes
Interventional
Not applicable
Nashville, Tennessee, 37232, United States
This study will involve two in-person research evaluations in the hospital that will last 45 minutes- 1 hour and will consist of a screening, breathing and cough testing, swallow function testing, measures of frailty, and completion of questionnaires. Following the initial research evaluation, critically ill adults will complete the intervention they are assigned to as prescribed. The exercises will take 15-20 minutes to complete and adherence to treatment will be tracked. Prior to hospital discharge and after completion of the intervention, critically ill adults will undergo a second research evaluation.
Clinical speech-language pathologists will complete questionnaires about the interventions that will take 10-15 minutes.
A subset of critically ill adults and clinical speech-language pathologists will also have the opportunity to participate in focus groups, which will take 45 minutes-1 hour.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
for critically ill adults will be:
Inclusion criteria
for speech-language pathologists (SLPs) will be:
EMST devices will be set to 60% of participants' maximum expiratory pressure. Participants will complete training 5 days per week by performing 5 sets of 5 repetitions.
Critically ill adults will perform one set of ten repetitions of each exercise recommended by their clinical speech-language pathologist. Enrolled participants will complete up to two training sessions per week (0-2 pending normal clinical care course) with a clinical speech-language pathologist
Critically ill adults will perform one set of ten repetitions of each exercise (effortful swallow, Masako maneuver, Mendelsohn maneuver, chin tuck against resistance, tongue strengthening exercises, and may also participate in bolus driven therapy). Enrolled participants will complete five training sessions per week (at least 3 days/week with the PI or a trained member of the research team and up to 2 days/week with a member of the clinical speech-language pathology team).
Time frame: pre-treatment (baseline), and post-treatment prior to hospital discharge, assessed up to 2 weeks
The DIGEST is a validated, 5-point ordinal rating scale that quantifies global pharyngeal swallow function.
Time frame: pre-treatment (baseline), and post-treatment prior to hospital discharge, assessed up to 2 weeks
The penetration aspiration scale is a validated 8-point ordinal rating scale that measures the depth of airway invasion and the patient's response during swallowing. Scores range from 1 to 8 with a score of 1 indicating a safe swallow (best score) and 8 indicating silent aspiration (worst score).
Time frame: pre-treatment (baseline), and post-treatment prior to hospital discharge, assessed up to 2 weeks
A measure of respiratory strength while breathing out
Time frame: pre-treatment (baseline), and post-treatment prior to hospital discharge, assessed up to 2 weeks
A measure of cough strength
Time frame: pre-treatment (baseline), and post-treatment prior to hospital discharge, assessed up to 2 weeks
Change in Grip strength be used to quantify clinical frailty using a digital hand dynamometer.
Time frame: pre-treatment (baseline), and post-treatment prior to hospital discharge, assessed up to 2 weeks
Scores on the SERF range 0-48 with higher scores indicating greater impairment.
Time frame: pre-treatment (baseline), and post-treatment prior to hospital discharge, assessed up to 2 weeks
Oral frailty will be assessed as present/absent using the Screening for Oral Frailty Tool.
Time frame: pre-treatment (baseline), and post-treatment prior to hospital discharge, assessed up to 2 weeks
The EAT-10 contains 10 questions (score range: 0-40), higher scores indicate greater impairment.
Time frame: post-treatment prior to hospital discharge, assessed up to 2 weeks
A measure of how acceptable an intervention is with scores ranging from 4-20.
Time frame: post-treatment prior to hospital discharge, assessed up to 2 weeks
A measure of how appropriate an intervention is with scores ranging from 4-20.
Time frame: post-treatment prior to hospital discharge, assessed up to 2 weeks
A measure of how feasible an intervention is with scores ranging from 4-20.
Contact information is provided by the study sponsor or research team.
Vanderbilt University Medical Center
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06190171
Cough, Deglutition Disorders
Nashville, Tennessee, United States
View Trial DetailsNCT07076524
Atrophy, Critical Illness
London, United Kingdom
View Trial DetailsNCT06579989
Cough, Cranial Nerve Diseases
New York, United States
View Trial DetailsNCT05913882
ALS, Behavior
Fort Lauderdale, Florida, United States
View Trial Details